The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCAT 2024 | The impact of biological sex in sickle cell disease
David Rees, FRCP, FRCPath, FRCPCH, King’s College London, London, UK, provides insight into the impact of biological sex in patients with sickle cell disease (SCD), highlighting the main differences that have been identified between male and female patients and the effect these have on disease outcomes. This interview took place at the 19th Annual Scientific Conference of the Academy for Sickle Cell and Thalassaemia (ASCAT 2024) in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
